NASDAQ:SNCE Science 37 (SNCE) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$5.75▼$5.7550-Day Range$5.68▼$5.7552-Week Range$3.73▼$12.96VolumeN/AAverage Volume43,227 shsMarket Capitalization$34.33 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Get Science 37 alerts: Email Address Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About Science 37 Stock (NASDAQ:SNCE)Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.Read More Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. SNCE Stock News HeadlinesJuly 20, 2024 | msn.comHow ‘Evo Moment #37’ Became the Greatest Viral Clip in Esports HistoryJuly 19, 2024 | tmcnet.comScience 37 Enrolls 42% of Trial Cohort in 8 WeeksJuly 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.June 27, 2024 | globenewswire.comScience 37 Quickly Impacts Performance in Under-Enrolling Clinical TrialsJune 12, 2024 | globenewswire.comCORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialMay 13, 2024 | markets.businessinsider.comScience 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceMay 13, 2024 | globenewswire.comScience 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and ComplianceMay 9, 2024 | globenewswire.comScience 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”July 27, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 2, 2024 | globenewswire.comScience 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical TrialApril 17, 2024 | markets.businessinsider.comScience 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentApril 17, 2024 | globenewswire.comScience 37 Provides Fully Consented Patients to Sites to Supplement EnrollmentMarch 12, 2024 | prnewswire.comeMed completes tender offer for all outstanding shares of Science 37February 27, 2024 | businesswire.comSCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCEFebruary 12, 2024 | finance.yahoo.comeMed commences tender offer for Science 37February 10, 2024 | businesswire.comSCIENCE 37 HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Science 37 Holdings, Inc. - SNCEFebruary 10, 2024 | markets.businessinsider.comScience 37 Initiates Cost-Cutting, Workforce Reduction PlanFebruary 4, 2024 | morningstar.comScience 37 Holdings Inc SNCESee More Headlines Receive SNCE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Science 37 and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolNASDAQ:SNCE CUSIPN/A CIK1819113 Webwww.lifesciacquisition.com Phone984-377-3737FaxN/AEmployees460Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($21.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-50,990,000.00 Net Margins-206.86% Pretax Margin-207.00% Return on Equity-83.09% Return on Assets-61.58% Debt Debt-to-Equity RatioN/A Current Ratio4.17 Quick Ratio4.17 Sales & Book Value Annual Sales$60.26 million Price / Sales0.57 Cash FlowN/A Price / Cash FlowN/A Book Value$16.70 per share Price / Book0.34Miscellaneous Outstanding Shares5,970,000Free Float5,564,000Market Cap$34.33 million OptionableNot Optionable Beta0.55 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. David Coman (Age 54)CEO & Director Comp: $796.13kMs. Christine A. Pellizzari J.D. (Age 56)Chief Legal & Human Resources Officer and Secretary Comp: $521.58kMs. Darcy Forman (Age 48)Chief Delivery Officer Comp: $550.58kMr. Mike Zaranek (Age 53)Chief Financial Officer Irena LambridisVP and Head of Quality Assurance & ComplianceMs. Margie Gimbel KoomanVice President of Marketing & CommunicationsMr. Drew BustosChief Strategy & Marketing OfficerMr. Jonathan Cotliar M.D. (Age 52)Chief Medical Officer Comp: $486.6kMr. Michael Shipton (Age 52)Chief Commercial Officer Mr. Tyler Van HornVP of Corporate Strategy & Chief of StaffMore ExecutivesKey CompetitorsForianNASDAQ:FORAAclarionNASDAQ:ACONWBrightSpring Health ServicesNASDAQ:BTSGUBullfrog AINASDAQ:BFRGWCareCloudNASDAQ:CCLDPView All Competitors SNCE Stock Analysis - Frequently Asked Questions When did Science 37's stock split? Science 37 shares reverse split on Friday, December 8th 2023. The 1-20 reverse split was announced on Friday, December 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. This page (NASDAQ:SNCE) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Science 37 Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Science 37 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.